Ayble Health secured $16 million in Series A funding to support a virtual digestive health clinic, according to the company’s financing update. The round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, and Accomplice. The investment underscores continued appetite for clinically oriented digital care models in gastrointestinal disease management, where remote triage, follow-up, and care coordination can reduce friction in specialty access. The presence of Cleveland Clinic Ventures also highlights the role of health-system-backed capital in digital health execution. For biotech and healthcare product developers, the funding is relevant as virtual specialty care platforms increasingly influence evidence generation, data capture, and patient journey design for GI therapeutics and diagnostics. While the article does not detail product metrics, the capital raise suggests Ayble is scaling operations and technology to widen capacity for digestive health patients. The Series A also adds another funding datapoint for virtual specialty services, which are competing for both clinical and commercial partnerships.